Stockscreener 앱 받기
0.6226
9.42%
0.0536
시간 외 거래:
.62
-0.0026
-0.42%
전일 마감가:
$0.569
열려 있는:
$0.57
하루 거래량:
121.27K
Relative Volume:
0.77
시가총액:
$2.34M
수익:
$2.28M
순이익/손실:
$-3.71M
주가수익비율:
-0.1853
EPS:
-3.36
순현금흐름:
$-3.60M
1주 성능:
+13.65%
1개월 성능:
+24.49%
6개월 성능:
-15.41%
1년 성능:
-20.79%
1일 변동 폭
$0.57
$0.6226
1주일 범위
$0.4756
$0.6226
52주 변동 폭
$0.4575
$1.5499
Nanovibronix Inc Stock (NAOV) Company Profile
명칭
Nanovibronix Inc
전화
(914) 233-3004
주소
525 EXECUTIVE BLVD, ELMSFORD
Nanovibronix Inc 주식(NAOV)의 최신 뉴스
A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News
Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
NanoVibronix faces potential Nasdaq delisting - Investing.com India
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com Canada
NanoVibronix Forges Potential New Distribution Deal - MPO-mag
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan
NanoVibronix stock hits 52-week low at $0.52 - Investing.com India
NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia
NanoVibronix explores UroShield distribution in Israel - Investing.com
NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan
NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE
Audit raises transparency concerns in IPO utilisation - The Business Post
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine
NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers
Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver
NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech
NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World
NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World
NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com
NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan
NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com
NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com
NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance
NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World
NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com
NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex
Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World
NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World
Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail
NanoVibronix Announces Reverse Stock Split - Quantisnow
NanoVibronix Reports Progress on Three Clinical Trials - Yahoo News UK
NanoVibronix’s PainShield Included in V.A. Contract - MPO-mag
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.79 - Defense World
NanoVibronix (NASDAQ:NAOV) Shares Pass Below 50 Day Moving Average of $0.80 - Defense World
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's ... - Yahoo Movies UK
NanoVibronix Issues Letter to Stockholders - citybiz
NanoVibronix Shares Q1 2024 Performance and Business UpdateTipRanks.com - TipRanks
NanoVibronix reports highest Q1 revenue, eyes growth By Investing.com - Investing.com
Nanovibronix Inc (NAOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
1.00%
자본화:
|
볼륨(24시간):